RESEARCH INDICATIONKnee osteoarthritis
Preclinical development
Cartilage repair & joint function
Home Defined by need.
OUR PIPELINE
Defined by need.
Developed through evidence.
A focused portfolio of engineered biological candidates, with each program evaluated against its own scientific, manufacturing and clinical requirements.
DEVELOPMENT SNAPSHOT · SEPTEMBER 2026
3 programs shown
PROGRAM / MODALITYRESEARCH INDICATIONDEVELOPMENT FOCUS
RESEARCH INDICATIONIdiopathic pulmonary fibrosis
Product design & preclinical evaluation
Pulmonary delivery & fibrosis biology
RESEARCH INDICATIONSevere lower-limb ischemia
Translational development
Perfusion & tissue repair
These descriptions summarize current research directions rather than regulatory phase designations. Product-specific filings, study authorizations and enrollment are separate milestones.
A BROADER RESEARCH BASE
Building the next
generation of candidates.
Our September 2026 portfolio planning identifies four priority translational projects and eight research-stage projects. These planning groups are not counts of approved clinical studies.
Immune-cell programs
Autologous, allogeneic and engineered NK-cell concepts are being explored in defined oncology and hematology settings.
40+ candidate factors
A research base across five therapeutic areas supports target evaluation, expression studies and product selection.
Evidence at each step
Candidate selection depends on mechanism, reproducibility, manufacturability and a credible development pathway.
DEVELOPMENT PRINCIPLES
The right evidence.
For each next step.
What does “investigational” mean?
The candidate remains in research or development. The descriptions on this website do not establish safety, efficacy or authorization for commercial use.
How do we describe clinical readiness?
Product definition, nonclinical evidence, manufacturing readiness, institutional review, study filing and patient enrollment are assessed separately. Completion of one does not imply completion of the others.
How can partners evaluate a program?
Contact our business development team to discuss a program-specific review. The scope of information sharing, available evidence and cooperation terms can be agreed for each opportunity.
PARTNER WITH LOTUSLAKE
A shared ambition.
A specific opportunity.
Bring a clinical challenge, a scientific discovery or a development ambition. Let’s explore what we can build together.
Start a conversation